Ling Qiu

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

D. Fairlie, C. Hansen, P. Parsons, 1999, British Journal of Cancer.

Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.

D. Fairlie, P. Parsons, B. Gabrielli, 2000, Molecular biology of the cell.

Serine protease inhibition and mitochondrial dysfunction associated with cisplatin resistance in human tumor cell lines: targets for therapy.

J. Dickinson, P. Parsons, Y. Dong, 1997, Biochemical pharmacology.